161 related articles for article (PubMed ID: 29724202)
1. Anti-Brucella activity of Caryopteris mongolica Bunge root extract against Brucella melitensis infection in mice.
N T; B N; O O; D D; J B
BMC Complement Altern Med; 2018 May; 18(1):144. PubMed ID: 29724202
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB/c mice.
Grilló MJ; De Miguel MJ; Muñoz PM; Marín CM; Ariza J; Blasco JM
J Antimicrob Chemother; 2006 Sep; 58(3):622-6. PubMed ID: 16849379
[TBL] [Abstract][Full Text] [Related]
3. Comparative activity of azithromycin and doxycycline against Brucella spp. infection in mice.
Domingo S; Gastearena I; Vitas AI; López-Goñi I; Dios-Viéitez C; Díaz R; Gamazo C
J Antimicrob Chemother; 1995 Oct; 36(4):647-56. PubMed ID: 8591939
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of ciprofloxacin versus doxycycline as prophylaxis against experimental murine Brucella melitensis infection.
Atkins HS; Spencer S; Brew SD; Jenner DC; Russell P; MacMillan AP; Eley SM; Simpson AJ
Int J Antimicrob Agents; 2009 Nov; 34(5):474-6. PubMed ID: 19500948
[TBL] [Abstract][Full Text] [Related]
5. In vitro assay for the anti-Brucella activity of medicinal plants against tetracycline-resistant Brucella melitensis.
Motamedi H; Darabpour E; Gholipour M; Seyyed Nejad SM
J Zhejiang Univ Sci B; 2010 Jul; 11(7):506-11. PubMed ID: 20593515
[TBL] [Abstract][Full Text] [Related]
6. Nanotherapeutic provides dose sparing and improved antimicrobial activity against Brucella melitensis infections.
Lueth P; Haughney SL; Binnebose AM; Mullis AS; Peroutka-Bigus N; Narasimhan B; Bellaire BH
J Control Release; 2019 Jan; 294():288-297. PubMed ID: 30572034
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of moxifloxacin or gatifloxacin as prophylaxis against experimental murine Brucella melitensis infection.
Atkins HS; Spencer S; Brew SD; Laws TR; Thirlwall RE; MacMillan AP; Brooks TJ; Simpson AJ
Int J Antimicrob Agents; 2009 Nov; 34(5):471-3. PubMed ID: 19682862
[TBL] [Abstract][Full Text] [Related]
8. Inadequate azithromycin activity against Brucella melitensis in mice with acute or chronic infections.
Domingo S; Gamazo C
J Chemother; 1996 Feb; 8(1):55-8. PubMed ID: 8835110
[TBL] [Abstract][Full Text] [Related]
9. Targeting Brucella melitensis with polymeric nanoparticles containing streptomycin and doxycycline.
Seleem MN; Jain N; Pothayee N; Ranjan A; Riffle JS; Sriranganathan N
FEMS Microbiol Lett; 2009 May; 294(1):24-31. PubMed ID: 19493005
[TBL] [Abstract][Full Text] [Related]
10. Acute Brucella melitensis M16 infection model in mice treated with tumor necrosis factor-alpha inhibitors.
Kutlu M; Ergin Ç; Şen-Türk N; Sayin-Kutlu S; Zorbozan O; Akalın Ş; Şahin B; Çobankara V; Demirkan N
J Infect Dev Ctries; 2015 Feb; 9(2):141-8. PubMed ID: 25699488
[TBL] [Abstract][Full Text] [Related]
11. The effect of long-term ethanol feeding on efficacy of doxycycline plus rifampicin in the treatment of experimental brucellosis caused by Brucella melitensis in rats.
Yumuk Z; Dundar V
J Chemother; 2005 Oct; 17(5):509-13. PubMed ID: 16323439
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey.
Denk A; Demirdag K; Kalkan A; Ozden M; Cetinkaya B; Kilic SS
Infect Dis (Lond); 2015 Jun; 47(6):364-9. PubMed ID: 25712728
[TBL] [Abstract][Full Text] [Related]
13. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Ulanqab of Inner Mongolia, China.
Liu ZG; Di DD; Wang M; Liu RH; Zhao HY; Piao DR; Zhao ZZ; Hao YQ; Du YN; Jiang H; Cui BY; Xia XZ
BMC Infect Dis; 2018 Jan; 18(1):43. PubMed ID: 29338693
[TBL] [Abstract][Full Text] [Related]
14. CXCR2 Mediates Brucella-Induced Arthritis in Interferon γ-Deficient Mice.
Lacey CA; Keleher LL; Mitchell WJ; Brown CR; Skyberg JA
J Infect Dis; 2016 Jul; 214(1):151-60. PubMed ID: 26951819
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Brucellosis in Guinea Pigs via a Combination of Engineered Novel pH-Responsive Curcumin Niosome Hydrogel and Doxycycline-Loaded Chitosan-Sodium Alginate Nanoparticles: an In Vitro and In Vivo Study.
Abo El-Ela FI; Hussein KH; El-Banna HA; Gamal A; Rouby S; Menshawy AMS; El-Nahass ES; Anwar S; Zeinhom MMA; Salem HF; Al-Sayed MAY; El-Newery HA; Shokier KAM; El-Nesr KA; Hosein HI
AAPS PharmSciTech; 2020 Nov; 21(8):326. PubMed ID: 33206259
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis against experimental murine Brucella melitensis infection.
Atkins HS; Spencer S; Brew SD; Jenner DC; Sefton AM; MacMillan AP; Brooks TJ; Simpson AJ
Int J Antimicrob Agents; 2010 Jul; 36(1):66-8. PubMed ID: 20022474
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic treatment induces an increase of the specific antibody levels in Brucella melitensis infected mice.
Domingo S; Díaz R; Gamazo C
FEMS Immunol Med Microbiol; 1995 Oct; 12(2):91-5. PubMed ID: 8589668
[TBL] [Abstract][Full Text] [Related]
18. Therapy of experimental murine brucellosis with streptomycin alone and in combination with ciprofloxacin, doxycycline, and rifampin.
Lang R; Shasha B; Rubinstein E
Antimicrob Agents Chemother; 1993 Nov; 37(11):2333-6. PubMed ID: 8285615
[TBL] [Abstract][Full Text] [Related]
19. Doxycycline-encapsulated solid lipid nanoparticles for the enhanced antibacterial potential to treat the chronic brucellosis and preventing its relapse: in vivo study.
Hosseini SM; Farmany A; Abbasalipourkabir R; Soleimani Asl S; Nourian A; Arabestani MR
Ann Clin Microbiol Antimicrob; 2019 Nov; 18(1):33. PubMed ID: 31706304
[TBL] [Abstract][Full Text] [Related]
20. Effect of early antibiotic treatment on the antibody response to cytoplasmic proteins of Brucella melitensis in mice.
Bowden RA; Racaro GC; Baldi PC
Clin Diagn Lab Immunol; 1999 May; 6(3):440-3. PubMed ID: 10225853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
